Explore more publications!

Tomorrow BioTech & Green2Gold Partner to Accelerate Sustainable Biotech and Green Innovation

#1 Non-Profit Biotech Incubator

Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to real-world impact.

By uniting TBTBADASS Labs’ biotech infrastructure with Green2Gold’s mentorship, we’re helping innovators turn breakthrough ideas into world-changing solutions.”
— David Kiewlich
ALAMEDA, CA, UNITED STATES, March 4, 2026 /EINPresswire.com/ -- Tomorrow BioTech / BADASS Labs, a nonprofit biotech incubator headquartered in Alameda, California, and Green2Gold, a pioneering global impact incubator and 501(c)(3) nonprofit based in California and Maui, Hawaii, today announced a strategic partnership designed to combine cutting-edge laboratory infrastructure with decades of innovation mentorship and commercialization expertise. Together, the two organizations aim to create a powerful support ecosystem for biotech startups, green technology ventures, inventors, and scientific entrepreneurs working to solve some of the world’s most pressing environmental and technological challenges.

The partnership brings together Tomorrow BioTech / BADASS Labs’ world-class shared and private laboratory facilities — including 24/7 equipment access, cold storage, tissue culture suites, and advanced scientific instrumentation — with Green2Gold’s more than 55 years of experience incubating and accelerating hundreds of impact-driven companies and projects across clean energy, sustainable ecology, and green technology sectors. The result is a comprehensive platform designed to help innovators move from early-stage research and development through commercialization, funding, and market launch.

According to the National Business Incubation Association (NBIA), ventures operating within incubators achieve an 89% success rate, compared with roughly a 90% failure rate for startups attempting to scale independently. By combining laboratory resources, mentorship, operational support, and commercialization guidance, the alliance between BADASS Labs and Green2Gold seeks to significantly improve the chances of success for emerging scientific and sustainability-focused ventures.

“Science advances fastest when infrastructure and community support are not obstacles,” said David Kiewlich, Founder of Tomorrow BioTech / BADASS Labs. “By partnering with Green2Gold and Professor Alan Tratner, we’re expanding our ability to support innovators not just with lab space and equipment, but also with the mentorship, commercialization strategy, and funding pathways that turn groundbreaking science into real-world solutions.”

“For more than five decades, Green2Gold has helped inventors and entrepreneurs bring breakthrough ideas from concept to market,” said Green2Gold International Founder Professor Alan Tratner. “This alliance with Tomorrow BioTech / BADASS Labs gives our innovators direct access to the laboratory infrastructure needed to validate, prototype, and scale biotech and green technology innovations. Together we are building one of the most comprehensive launch platforms for responsible innovation and meaningful impact.”

By combining BADASS Labs’ operational infrastructure with Green2Gold’s innovation ecosystem, the partnership offers founders and scientists a wide range of resources. Entrepreneurs will gain full laboratory access, including shared and private lab space, advanced equipment, cold storage, and tissue culture suites across BADASS Labs’ Alameda locations. Innovators will also benefit from commercialization and mentorship support through Green2Gold’s incubation and co-venture model, including strategic business advising, intellectual property guidance, and connections to licensing partners and investors.

Operational support services — such as purchasing assistance, regulatory guidance, waste management coordination, and vendor partnerships — will help reduce early-stage barriers and streamline development. Funding pathways will also be available through Green2Gold’s partnerships with impact accelerators and financial organizations supporting multiple types of investment opportunities.

Both organizations bring strong track records to the collaboration. Tomorrow BioTech / BADASS Labs reports a 90% success rate among supported companies, helping startups move faster, stay compliant, and scale with confidence. Green2Gold contributes more than five decades of global experience incubating impact-driven companies and projects across the green economy.

In today’s competitive biotech and cleantech landscape, early access to laboratory infrastructure, mentorship, and funding pathways can determine whether breakthrough innovations reach the market. This partnership removes major barriers to entry while connecting lab-ready startups with decades of entrepreneurial expertise and global networks.

The collaboration was further strengthened through connections made at the global three-day SuperGreen Live event co-hosted by The Super Crowd, Inc., a public benefit corporation led by founder and CEO Devin Thorpe.

Together, Tomorrow BioTech / BADASS Labs and Green2Gold are building a collaborative platform designed to empower the next generation of scientists, entrepreneurs, and innovators with the tools, mentorship, infrastructure, and community needed to transform bold ideas into solutions that benefit both humanity and the planet.

David Kiewlich
BADASS Labs
+1 510-824-4353
email us here
Visit us on social media:
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions